Related Experiment Video
Updated: May 11, 2026
Breath Collection from Children for Disease Biomarker Discovery
Published on: February 14, 2019
Bridging the Gap: Exploring Bronchopulmonary Dysplasia through the Lens of Biomedical Informatics
Jennifer Kim1, Mariela Villarreal1, Shreyas Arya2
1Division of Neonatology, Department of Pediatrics, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
Insights
Biomedical informatics (BMI) offers innovative solutions for bronchopulmonary dysplasia (BPD) research and care. BMI enhances data analysis, enabling personalized medicine and predictive analytics for improved infant lung disease management.
Area of Science:
- Biomedical Informatics
- Neonatology
- Computational Biology
Background:
- Bronchopulmonary dysplasia (BPD) is a prevalent chronic lung disease in premature infants, presenting significant clinical challenges.
- Current research and care strategies for BPD require innovative, data-driven approaches due to disease complexity and escalating healthcare impact.
Purpose of the Study:
- To explore the transformative potential of biomedical informatics (BMI) in advancing bronchopulmonary dysplasia (BPD) research and clinical management.
- To highlight how BMI can address limitations in conventional BPD research and facilitate personalized medicine and predictive analytics.
Main Methods:
- Review of existing literature on biomedical informatics applications in respiratory diseases and neonatology.
- Exploration of BMI tools including big data analytics, genomics, predictive modeling, and mobile health technologies.
- Discussion of ethical and legal considerations pertinent to BMI implementation in BPD research.
Main Results:
- BMI provides robust tools for managing and analyzing diverse biomedical data crucial for understanding BPD.
- Genomic data analysis through BMI can identify biomarkers and inform personalized treatment strategies for BPD.
- Predictive analytics and mobile health technologies offer potential for early diagnosis, risk assessment, and enhanced patient monitoring in BPD.
Conclusions:
- Biomedical informatics holds significant promise for revolutionizing BPD research by enabling data-driven insights.
- BMI facilitates the development of personalized medicine and predictive analytics, leading to improved interventions and outcomes for infants with BPD.
- Addressing ethical and legal aspects is crucial for the successful integration of BMI in BPD research and care.
Abstract:
Bronchopulmonary dysplasia (BPD), a chronic lung disease predominantly affecting premature infants, poses substantial clinical challenges. This review delves into the promise of biomedical informatics (BMI) in reshaping BPD research and care. We commence by highlighting the escalating prevalence and healthcare impact of BPD, emphasizing the necessity for innovative strategies to comprehend its intricate nature. To this end, we introduce BMI as a potent toolset adept at managing and analyzing extensive, diverse biomedical data. The challenges intrinsic to BPD research are addressed, underscoring the inadequacies of conventional approaches and the compelling need for data-driven solutions. We subsequently explore how BMI can revolutionize BPD research, encompassing genomics and personalized medicine to reveal potential biomarkers and individualized treatment strategies. Predictive analytics emerges as a pivotal facet of BMI, enabling early diagnosis and risk assessment for timely interventions. Moreover, we examine how mobile health technologies facilitate real-time monitoring and enhance patient engagement, ultimately refining BPD management. Ethical and legal considerations surrounding BMI implementation in BPD research are discussed, accentuating issues of privacy, data security, and informed consent. In summation, this review highlights BMI's transformative potential in advancing BPD research, addressing challenges, and opening avenues for personalized medicine and predictive analytics.
